
Selank
- Evidence
- Limited research
- Class
- Anxiolytic peptide (Russian)
Selank belongs to the Anxiolytic peptide (Russian) class. This library groups it under brain & sleep. Its source category is Not FDA-approved.
At a glance
| Compound class | Anxiolytic peptide (Russian) |
|---|---|
| Body system | Brain & sleep |
| Use or research focus | Anxiety, focus |
| Regulatory status | Not FDA-approved (approved in Russia) |
| Source evidence rating | Limited research |
How does Selank work?
Modulates GABA/serotonin, tuftsin analog.
The source catalog maps this mechanism to Brain / CNS. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.
What does the evidence tell us?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.
Safety and considerations
For an unapproved use or compound, safety and effectiveness may be uncertain. Products sold for research are not a substitute for prescribed care. Do not infer a human dose, injection protocol, or treatment recommendation from preclinical research.
This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.
Common questions
What is Selank?
Selank belongs to the Anxiolytic peptide (Russian) class. This library groups it under brain & sleep. Its source category is Not FDA-approved. Its recorded use or research focus is: Anxiety, focus.
Is Selank FDA-approved?
The catalog records: Not FDA-approved (approved in Russia). Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.
How strong is the research?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Where can I read the research?
The Citations tab contains 11 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.
More for brain & sleep
Factual catalog fields and citation links are adapted from Superpower’s Selank guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.
Sources & further reading
References associated with Selank in the source dataset. Open a source to review its study design, population, limitations, and date.
- 01studydoi.org
- 02analytical reviewdoi.org
- 03BDNF and NGFdoi.org
- 04FDA staff opposedstatnews.com
- 05generalized anxiety disorder and neurastheniapubmed.ncbi.nlm.nih.gov
- 06nominated but withdrawnfda.gov
- 07secondary immunomodulatory propertiespubmed.ncbi.nlm.nih.gov
- 08allosteric modulation of the GABA systemdoi.org
- 09both reduced anxiety-like behaviorpubmed.ncbi.nlm.nih.gov
- 10Category 2fda.gov
- 11July 2026 advisory committee agendafda.gov





